Skip to main content
HIGH TECH PHARM CO.,LTD. logo

HIGH TECH PHARM CO.,LTD. — Investor Relations & Filings

Ticker · 106190 ISIN · KR7106190002 KO Manufacturing
Open in API
Filings indexed 169 across all filing types
Latest filing 2025-03-06 Proxy Solicitation & In…
Country KR South Korea
Listing KO 106190

About HIGH TECH PHARM CO.,LTD.

http://www.htpharm.com/eng/

HIGH TECH PHARM CO.,LTD. is a pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on sterile, carbapenem-based antibiotic raw materials. Established in 1998, the company has gained global recognition for its advanced technology and high-quality products, which are supplied to over 40 countries. A significant majority of its sales are generated from exports to demanding overseas markets, including Europe. The company operates state-of-the-art manufacturing facilities, such as its Chungju plant, designed to meet the rigorous standards of advanced regulatory authorities like the U.S. FDA and European EDQM. Through a commitment to a quality-first policy and continuous research and development, HIGH TECH PHARM aims to solidify its position as a leading global supplier of antibiotic drug substances.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for the 27th Annual General Meeting of HT Pharm. It contains the meeting agenda, director candidate information, financial statements, and governance details. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on matters at the upcoming meeting.
2025-03-06 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of an Annual General Meeting (AGM) for the company 'Hitech Pharm'. It details the date, location, agenda items (such as financial statement approval, director appointments, and dividend proposals), and board resolutions. This document serves as the official solicitation and notification to shareholders regarding the upcoming meeting, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2025-02-24 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal notification filed by Hitech Pharm regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for this scheduling and provides the expected notice date. Since this is a regulatory disclosure regarding meeting logistics rather than the AGM presentation materials themselves, and it does not fit into specific categories like voting results or proxy solicitation, it is classified as a general regulatory filing.
2025-02-24 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from '하이텍팜' (Hitech Pharm) regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2025-02-06 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Hitech Pharm) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. Since it provides the initial announcement of financial results (highlights) rather than a full annual report or a transcript, it falls under the Earnings Release category. FY 2024
2025-02-06 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a formal notice regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It specifies the record date (2024-12-31) and the reason (holding the 27th Annual General Meeting). Since this is a regulatory announcement regarding the preparation for an AGM rather than the AGM presentation materials themselves, and it does not fit into other specific categories like dividend announcements or proxy solicitations, it is classified as a general regulatory filing.
2024-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.